Basilea Pharmaceutica (Switzerland) Price History

BSLN Stock  CHF 40.65  0.45  1.09%   
If you're considering investing in Basilea Stock, it is important to understand the factors that can impact its price. As of today, the current price of Basilea Pharmaceutica stands at 40.65, as last reported on the 13th of December 2024, with the highest price reaching 41.40 and the lowest price hitting 40.60 during the day. Basilea Pharmaceutica secures Sharpe Ratio (or Efficiency) of -0.11, which signifies that the company had a -0.11% return per unit of risk over the last 3 months. Basilea Pharmaceutica AG exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Basilea Pharmaceutica's Standard Deviation of 1.29, risk adjusted performance of (0.08), and Mean Deviation of 1.02 to double-check the risk estimate we provide.
  
Basilea Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.1121

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsBSLN

Estimated Market Risk

 1.3
  actual daily
11
89% of assets are more volatile

Expected Return

 -0.15
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.11
  actual daily
0
Most of other assets perform better
Based on monthly moving average Basilea Pharmaceutica is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Basilea Pharmaceutica by adding Basilea Pharmaceutica to a well-diversified portfolio.

Basilea Pharmaceutica Stock Price History Chart

There are several ways to analyze Basilea Stock price data. The simplest method is using a basic Basilea candlestick price chart, which shows Basilea Pharmaceutica price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceSeptember 25, 202447.15
Lowest PriceNovember 19, 202439.75

Basilea Pharmaceutica December 13, 2024 Stock Price Synopsis

Various analyses of Basilea Pharmaceutica's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Basilea Stock. It can be used to describe the percentage change in the price of Basilea Pharmaceutica from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Basilea Stock.
Basilea Pharmaceutica Accumulation Distribution 248.71 
Basilea Pharmaceutica Price Rate Of Daily Change 0.99 
Basilea Pharmaceutica Price Action Indicator(0.58)
Basilea Pharmaceutica Price Daily Balance Of Power(0.56)

Basilea Pharmaceutica December 13, 2024 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in Basilea Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Basilea Pharmaceutica intraday prices and daily technical indicators to check the level of noise trading in Basilea Stock and then apply it to test your longer-term investment strategies against Basilea.

Basilea Stock Price History Data

The price series of Basilea Pharmaceutica for the period between Sat, Sep 14, 2024 and Fri, Dec 13, 2024 has a statistical range of 7.4 with a coefficient of variation of 5.12. The prices are distributed with arithmetic mean of 43.36. The median price for the last 90 days is 44.2. The company had 1039:1029 stock split on 13th of March 2007. Basilea Pharmaceutica issued dividends on 2013-04-11.
OpenHighLowCloseVolume
12/12/2024 41.00  41.40  40.60  40.65  12,871 
12/11/2024 41.00  41.30  41.00  41.10  16,122 
12/10/2024 40.40  41.35  40.40  41.20  21,533 
12/09/2024 40.40  41.15  40.35  40.55  30,513 
12/06/2024 39.90  40.35  39.90  40.25  23,696 
12/05/2024 40.10  40.65  39.85  40.05  49,248 
12/04/2024 40.75  41.00  39.60  40.10  41,664 
12/03/2024 40.95  41.35  40.40  40.90  18,052 
12/02/2024 41.80  41.90  40.70  40.95  21,108 
11/29/2024 41.25  41.80  41.10  41.70  11,662 
11/28/2024 40.95  41.90  40.95  41.40  15,628 
11/27/2024 40.65  41.00  40.45  40.85  21,588 
11/26/2024 42.20  42.20  40.35  40.60  32,534 
11/25/2024 41.25  42.10  40.95  42.10  95,926 
11/22/2024 40.45  41.35  40.45  41.30  34,089 
11/21/2024 40.20  40.60  39.95  40.55  29,016 
11/20/2024 39.90  40.70  39.80  40.35  30,015 
11/19/2024 39.80  39.95  38.90  39.75  28,348 
11/18/2024 40.00  40.25  39.40  39.80  26,371 
11/15/2024 40.20  40.25  39.60  40.00  35,995 
11/14/2024 41.00  41.00  40.45  40.70  15,065 
11/13/2024 41.00  41.15  40.20  41.00  35,360 
11/12/2024 41.60  41.65  41.00  41.20  44,684 
11/11/2024 42.20  42.60  41.80  41.80  46,188 
11/08/2024 43.40  43.40  42.00  42.20  22,028 
11/07/2024 42.75  43.00  42.30  42.50  12,521 
11/06/2024 43.15  43.75  42.60  42.60  13,906 
11/05/2024 43.35  43.70  42.75  43.10  16,229 
11/04/2024 43.45  43.95  43.30  43.65  13,638 
11/01/2024 43.20  43.55  42.85  43.20  12,606 
10/31/2024 43.20  43.35  42.20  42.80  49,835 
10/30/2024 43.60  43.60  42.70  43.50  24,648 
10/29/2024 44.45  44.70  43.65  43.65  68,045 
10/28/2024 44.80  45.00  44.25  44.55  23,858 
10/25/2024 44.20  44.85  43.80  44.85  19,317 
10/24/2024 44.60  44.60  43.80  44.20  43,836 
10/23/2024 44.40  45.35  43.80  44.65  42,319 
10/22/2024 44.85  44.85  44.20  44.40  21,277 
10/21/2024 45.35  45.60  44.80  45.00  19,625 
10/18/2024 45.00  45.60  44.70  45.60  24,216 
10/17/2024 44.80  45.15  44.30  44.80  25,207 
10/16/2024 45.00  45.00  44.60  44.95  23,290 
10/15/2024 45.60  45.80  44.90  45.25  28,715 
10/14/2024 45.55  46.00  45.20  45.65  26,272 
10/11/2024 45.20  46.00  45.10  45.40  15,923 
10/10/2024 44.40  45.55  44.20  45.15  48,662 
10/09/2024 44.60  44.60  44.10  44.45  23,357 
10/08/2024 45.00  45.05  44.15  44.55  37,589 
10/07/2024 44.95  45.35  44.40  45.05  15,009 
10/04/2024 44.95  45.20  44.55  44.75  6,977 
10/03/2024 45.00  45.20  44.65  44.95  24,996 
10/02/2024 45.60  45.60  45.10  45.15  20,946 
10/01/2024 46.25  46.45  45.40  45.60  37,853 
09/30/2024 46.40  46.80  45.95  46.35  26,464 
09/27/2024 47.10  47.35  46.15  46.50  23,111 
09/26/2024 47.45  47.65  46.60  47.10  25,629 
09/25/2024 46.00  47.95  46.00  47.15  45,541 
09/24/2024 46.40  46.50  45.80  46.15  14,205 
09/23/2024 46.70  46.95  45.60  46.00  28,725 
09/20/2024 45.80  47.40  45.80  47.05  62,383 
09/19/2024 46.15  47.25  45.55  45.80  107,799 

About Basilea Pharmaceutica Stock history

Basilea Pharmaceutica investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Basilea is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Basilea Pharmaceutica will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Basilea Pharmaceutica stock prices may prove useful in developing a viable investing in Basilea Pharmaceutica
Basilea Pharmaceutica AG, a commercial stage biopharmaceutical company, focuses on the development of products that address the medical needs in the therapeutic areas of oncology and anti-infectives. The company was founded in 2000 and is headquartered in Basel, Switzerland. BASILEA N operates under Pharmaceuticals And Biosciences classification in Switzerland and is traded on Switzerland Exchange. It employs 160 people.

Basilea Pharmaceutica Stock Technical Analysis

Basilea Pharmaceutica technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Basilea Pharmaceutica technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Basilea Pharmaceutica trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Portfolio Diagnostics Now

   

Portfolio Diagnostics

Use generated alerts and portfolio events aggregator to diagnose current holdings
All  Next Launch Module

Basilea Pharmaceutica Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Basilea Pharmaceutica's price direction in advance. Along with the technical and fundamental analysis of Basilea Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Basilea to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Additional Tools for Basilea Stock Analysis

When running Basilea Pharmaceutica's price analysis, check to measure Basilea Pharmaceutica's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Basilea Pharmaceutica is operating at the current time. Most of Basilea Pharmaceutica's value examination focuses on studying past and present price action to predict the probability of Basilea Pharmaceutica's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Basilea Pharmaceutica's price. Additionally, you may evaluate how the addition of Basilea Pharmaceutica to your portfolios can decrease your overall portfolio volatility.